Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis Patients
NCT ID: NCT03807453
Last Updated: 2020-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2019-04-25
2019-06-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis
NCT03475914
Association Between Biologic Therapy and Demodex Density in Psoriasis Patients: A Comparative Study
NCT05954572
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
NCT05105139
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
NCT06357221
A Pilot Study to Explore the Role of Gut Flora in Psoriasis
NCT04099979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Psoriasis Vulgaris patients-Lesion
Microbiota
The scalp microbiota
Psoriasis Vulgaris patients-Lesion free
Microbiota
The scalp microbiota
Seborrheic Dermatitis-Lesion
Microbiota
The scalp microbiota
Seborrheic Dermatitis-Lesion free
Microbiota
The scalp microbiota
Control Group
Microbiota
The scalp microbiota
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microbiota
The scalp microbiota
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with seborrheic dermatitis
3. Agree to participate in research 4 - Do not use any drugs for their disease topically or systemically for two months
Exclusion Criteria
2. Patients with psoriasis vulgaris or seborrheic dermatitis that does not effect scalp.
3. Those with chronic diseases that may affect skin microbiome
4. Patients using antibiotics, antifungal or antiviral therapy for any reason for the last one month.
5. Patients who are using topical or systemic drugs for their illness
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Turkish Dermatology Association
UNKNOWN
Istanbul Medeniyet University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melek Aslan Kayıran
Dermatologist, M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Melek Aslan Kayıran
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IstanbulMU2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.